# The Role of Hepcidin as a Biomarker to Predict Successful Renal Transplantation

> **NCT04575077** · — · UNKNOWN · sponsor: **Yonsei University** · enrollment: 200 (estimated)

## Conditions studied

- End-stage Renal Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04575077
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-16
- **Primary completion:** 2022-02
- **Final completion:** 2022-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04575077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04575077, "The Role of Hepcidin as a Biomarker to Predict Successful Renal Transplantation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04575077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*